Immunome's varegacestat is in a phase 3 trial in patients with desmoid tumors that should produce results in H2'25. Read why I remain bullish on IMNM stock.

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Novo Nordisk shares were 9.5% higher after the pharmaceutical giant said an experimental weight-loss shot showed patients ...

Texas Instruments falls after the chip maker’s first-quarter earnings forecast misses estimates, and Boeing declines after ...

Amycretin could give Novo a buzzy product in a newly competitive obesity market. It works similarly to existing GLP-1 ...

KEY TAKEAWAYS Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage ...

British authorities arrested two drug traffickers belonging to a larger organized crime group, thanks largely to intelligence ...

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...

(AP Photo/Gregory Bull) Paraphernalia supporting President Donald Trump is displayed at a post on the floor of the New York ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...